Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
FTC Rejects Illumina's $7 Billion Deal for Cancer-Test Developer Grail
Business

FTC Rejects Illumina's $7 Billion Deal for Cancer-Test Developer Grail

The agency said the combination would hurt competition for cancer-detection tests while raising prices. Source link